Daily Archive: February 5, 2021

Bombardier to Report Fourth Quarter and Full Year 2020 Financial Results on February 11, 2021

MONTRÉAL, Feb. 05, 2021 (GLOBE NEWSWIRE) — Bombardier (TSX: BBD.B) will publish its financial results for the fourth quarter and full year ended December 31, 2020 on Thursday, February 11, 2021. On February 11, 2021 at 8:00 a.m., EST, Bombardier will hold a webcast/conference call intended for investors and financial analysts to review the company’s financial […]

Sanofi delivered close to double-digit Q4 2020 business EPS(1) growth at CER

Q4 2020 sales growth(2) of 4.2% and business EPS growth of 9.8% at CER  Specialty Care sales grew 18.3%, driven by strong Dupixent® performance (+54.2% to €982 million). Vaccines up 14.6%, driven by record demand for differentiated influenza vaccines and continued growth of PPH. General Medicines declined 7.5%, reflecting lower U.S. Diabetes sales, COVID environment […]

Amlan International Names Ricardo Ivanovski as Regional Technical Service Manager for Brazil

RICARDO IVANOVSKI CHICAGO, Feb. 04, 2021 (GLOBE NEWSWIRE) — Amlan International, a global leader in mineral-based feed additives that improve the intestinal health and efficiency of poultry and livestock, has named Ricardo Ivanovski as the new Technical Service Manager for Brazil. Ricardo will execute technical service support and ensure strong customer service in the region […]

Novavax Announces Start of Rolling Review by Multiple Regulatory Authorities for COVID-19 Vaccine Authorization

Rolling reviews have commenced by FDA, MHRA, EMA and Health Canada GAITHERSBURG, Md., Feb. 04, 2021 (GLOBE NEWSWIRE) — Novavax, Inc. (Nasdaq: NVAX), a biotechnology company developing next-generation vaccines for serious infectious diseases, today announced the start of the rolling review process for authorization of NVX-CoV2373, its COVID-19 vaccine, by multiple regulatory agencies. The reviews […]